Panacea Biotec reaches settlement with Apotex
Apotex will also pay US$ 2.5 million upon receipt of final USFDA approval of the ANDA that is the subject of the Collaboration Agreement for Paclitaxel Protein-Bound Particles for Injectable Suspension
Apotex will also pay US$ 2.5 million upon receipt of final USFDA approval of the ANDA that is the subject of the Collaboration Agreement for Paclitaxel Protein-Bound Particles for Injectable Suspension
The wholly owned subsidiary will carry on the business of all types of research and development and other related services
J B Chemicals and Pharmaceuticals receives ANDA approval for Amitriptyline Hydrochloride Tablets from USFDA
SUP will obtain regulatory approvals for selling Tiotropium DPI in China
These observations are procedural in nature and none of them are related to data integrity
Ami Organics’ Ankleshwar Unit II gets GMP compliant by PMDA Japan
Amaran Biotech boasts Taiwan’s first fully automated robotic aseptic filling line, offering high-quality and low-waste filling solutions for high-value pharmaceuticals
Biotech potential of Himalayan territories including Jammu & Kashmir, particularly their agri-biotech potential remains still under-explored
The recent EU approval of MBL's plant has opened new avenues to explore such opportunities
The inspection was successfully completed
Subscribe To Our Newsletter & Stay Updated